These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 2856170)

  • 1. CP-66,248, a new anti-inflammatory agent, is a potent inhibitor of leukotriene B4 and prostanoid synthesis in human polymorphonuclear leucocytes in vitro.
    Moilanen E; Alanko J; Asmawi MZ; Vapaatalo H
    Eicosanoids; 1988; 1(1):35-9. PubMed ID: 2856170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
    Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
    Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of antirheumatic drugs on leukotriene B4 and prostanoid synthesis in human polymorphonuclear leukocytes in vitro.
    Moilanen E; Alanko J; Seppälä E; Vapaatalo H
    Agents Actions; 1988 Jul; 24(3-4):387-94. PubMed ID: 2845746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of the butanamide derivative S 19812, a new dual inhibitor of cyclooxygenase and lipoxygenase pathways.
    Tordjman C; Sauveur F; Droual M; Briss S; Andre N; Bellot I; Deschamps C; Wierzbicki M
    Arzneimittelforschung; 2003; 53(11):774-9. PubMed ID: 14677373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tepoxalin: a dual cyclooxygenase/5-lipoxygenase inhibitor of arachidonic acid metabolism with potent anti-inflammatory activity and a favorable gastrointestinal profile.
    Argentieri DC; Ritchie DM; Ferro MP; Kirchner T; Wachter MP; Anderson DW; Rosenthale ME; Capetola RJ
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1399-408. PubMed ID: 7996452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fuscoside: an anti-inflammatory marine natural product which selectively inhibits 5-lipoxygenase. Part II: Biochemical studies in the human neutrophil.
    Jacobson PB; Jacobs RS
    J Pharmacol Exp Ther; 1992 Aug; 262(2):874-82. PubMed ID: 1323665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclooxygenase and lipoxygenase metabolite synthesis by polymorphonuclear neutrophils: in vitro effect of dipyrone.
    Abbate R; Gori AM; Pinto S; Attanasio M; Paniccia R; Coppo M; Castellani S; Giusti B; Boddi M; Neri Serneri GG
    Prostaglandins Leukot Essent Fatty Acids; 1990 Oct; 41(2):89-93. PubMed ID: 2177201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tenidap inhibits 5-lipoxygenase product formation in vitro, but this activity is not observed in three animal models.
    Carty TJ; Sweeney FJ; Griffiths RJ; Eskra JD; Ernest MJ; Pillar JS; Cheng JD; Loose LD; Joseph PA; Pazoles PP; Moore PF; Nagahisa A; Murase S; Kadin SB
    Inflamm Res; 1997 May; 46(5):168-79. PubMed ID: 9197987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays.
    Riendeau D; Charleson S; Cromlish W; Mancini JA; Wong E; Guay J
    Can J Physiol Pharmacol; 1997 Sep; 75(9):1088-95. PubMed ID: 9365818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phorbol myristate acetate and the calcium ionophore A23187 synergistically induce release of LTB4 by human neutrophils: involvement of protein kinase C activation in regulation of the 5-lipoxygenase pathway.
    Liles WC; Meier KE; Henderson WR
    J Immunol; 1987 May; 138(10):3396-402. PubMed ID: 3033073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of cytosolic phospholipase A(2) and 5-lipoxygenase activation in neutrophils by a natural isoflavanquinone abruquinone A.
    Hsu MF; Chang LC; Chen SC; Kuo SC; Lee HY; Lu MC; Wang JP
    Eur J Pharmacol; 2008 Nov; 598(1-3):123-31. PubMed ID: 18834875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenylsulphonyl urenyl chalcone derivatives as dual inhibitors of cyclo-oxygenase-2 and 5-lipoxygenase.
    Araico A; Terencio MC; Alcaraz MJ; Domínguez JN; León C; Ferrándiz ML
    Life Sci; 2006 May; 78(25):2911-8. PubMed ID: 16360707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. U-60,257 has no effect on the metabolism of arachidonic acid in nonstimulated human polymorphonuclear leukocytes.
    Dahl ML; Puustinen T; Uotila P
    Res Commun Chem Pathol Pharmacol; 1984 Jun; 44(3):355-65. PubMed ID: 6431565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orally administered tolfenamic acid inhibits leukotriene synthesis in isolated human peripheral polymorphonuclear leukocytes.
    Moilanen E; Alanko J; Juhakoski A; Vapaatalo H
    Agents Actions; 1989 Aug; 28(1-2):83-8. PubMed ID: 2551152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of acetylshikonin, a natural naphthoquinone, on the production of leukotriene B4 and thromboxane A2 in rat neutrophils.
    Hsu MF; Chang LC; Huang LJ; Kuo SC; Lee HY; Lu MC; Wang JP
    Eur J Pharmacol; 2009 Apr; 607(1-3):234-43. PubMed ID: 19232341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles.
    Chan CC; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Ford-Hutchinson AW; Forrest MJ; Gauthier JY; Gordon R; Gresser M; Guay J; Kargman S; Kennedy B; Leblanc Y; Leger S; Mancini J; O'Neill GP; Ouellet M; Patrick D; Percival MD; Perrier H; Prasit P; Rodger I
    J Pharmacol Exp Ther; 1999 Aug; 290(2):551-60. PubMed ID: 10411562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual inhibition of 5-lipoxygenase/cyclooxygenase by a reconstituted homeopathic remedy; possible explanation for clinical efficacy and favourable gastrointestinal tolerability.
    Jäggi R; Würgler U; Grandjean F; Weiser M
    Inflamm Res; 2004 Apr; 53(4):150-7. PubMed ID: 15060721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potencies of leflunomide and HR325 as inhibitors of prostaglandin endoperoxide H synthase-1 and -2: comparison with nonsteroidal anti-inflammatory drugs.
    Curnock AP; Robson PA; Yea CM; Moss D; Gadher S; Thomson TA; Westwood R; Ruuth E; Williamson RA
    J Pharmacol Exp Ther; 1997 Jul; 282(1):339-47. PubMed ID: 9223572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of aspirin on prostaglandin E2 and leukotriene B4 production in human colonic mucosa from cancer patients.
    Frommel TO; Dyavanapalli M; Oldham T; Kazi N; Lietz H; Liao Y; Mobarhan S
    Clin Cancer Res; 1997 Feb; 3(2):209-13. PubMed ID: 9815674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cyclo-oxygenase inhibition on exhaled eicosanoids in patients with COPD.
    Montuschi P; Macagno F; Parente P; Valente S; Lauriola L; Ciappi G; Kharitonov SA; Barnes PJ; Ciabattoni G
    Thorax; 2005 Oct; 60(10):827-33. PubMed ID: 16192367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.